Breaking News Instant updates and real-time market news.

BLFS

BioLife Solutions

$29.46 /

-0.845 (-2.79%)

16:18
05/13/21
05/13
16:18
05/13/21
16:18

BioLife Solutions reports Q1 non-GAAP EPS 1c, consensus (4c)

Reports Q1 revenue $16.8M, consensus $16.05M. CEO Mike Rice commented, "The entire BioLife team contributed to across-the-board excellent performance with total revenue reaching a record $16.8M. We gained 80 new customers in Q1 alone, compared with our stellar addition of 213 customers for FY20. We achieved record revenue from our media franchise as we gained 16 new media customers and received confirmation that our media will be used in an additional 13 customer clinical trials. (...) We expect our acquisition of Global Cooling will drive significant top-line growth in 2021," he added. "The combination of Stirling Ultracold and our recently launched high-capacity controlled rate freezer products opens new opportunities, as we now compete for the entire range of controlled temperature storage solutions. We expanded our leadership since the beginning of 2021, including welcoming former Stirling CEO, Dusty Tenney, as president and COO," said Mr. Rice. "We also named new leaders of our sales and human resources teams and added two new highly qualified board members to help guide our acquisition and integration strategies. In summary, we're configured to deliver transformational results in 2021".

  • 13

    May

  • 18

    Jun

  • 02

    Jul

BLFS BioLife Solutions
$29.46 /

-0.845 (-2.79%)

03/24/21 B. Riley
BioLife Solutions price target raised to $61 from $35.50 at B. Riley
03/23/21 Maxim
BioLife Solutions price target raised to $60 from $40 at Maxim
03/23/21 KeyBanc
BioLife Solutions price target raised to $50 from $40 at KeyBanc
03/23/21 Northland
BioLife Solutions acquisition of Stirling a 'major positive,' says Northland

TODAY'S FREE FLY STORIES

General news
Asian Market Update: » 02:00
09/23/21
09/23
02:00
09/23/21
02:00
$ECON

Economic Data

/

+

Asian Market Update:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
U.S. leading economic index preview » 02:00
09/23/21
09/23
02:00
09/23/21
02:00
$ECON

Economic Data

/

+

U.S. leading economic…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
U.S. jobless claims preview » 02:00
09/23/21
09/23
02:00
09/23/21
02:00
$ECON

Economic Data

/

+

U.S. jobless claims…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

Initiation
Anaergia initiated with an Outperform at BMO Capital » 21:56
09/22/21
09/22
21:56
09/22/21
21:56
ANRGF

Anaergia

$15.07 /

+ (+0.00%)

BMO Capital analyst John…

BMO Capital analyst John Gibson initiated coverage of Anaergia with an Outperform rating and C$35 price target. The company is shifting towards an asset ownership model, which should see "significant levels" of recurring revenue over the next several years, Gibson tells investors in a research note. The analyst believes Anaergia should see multiple expansion as it proves out its recurring revenue business model.

ShowHide Related Items >><<
ANRGF Anaergia
$15.07 /

+ (+0.00%)

09/13/21 National Bank
Anaergia initiated with a Sector Perform at National Bank
Syndicate
Rexford Industrial 9.6M share Spot Secondary priced at $58.95 » 21:38
09/22/21
09/22
21:38
09/22/21
21:38
REXR

Rexford Industrial

$60.18 /

+0.02 (+0.03%)

The deal range was…

The deal range was $58.95-$59.55. BofA and JPMorgan acted as joint book running managers for the offering.

ShowHide Related Items >><<
REXR Rexford Industrial
$60.18 /

+0.02 (+0.03%)

REXR Rexford Industrial
$60.18 /

+0.02 (+0.03%)

08/10/21 Wells Fargo
Rexford Industrial price target raised to $65 from $58 at Wells Fargo
07/19/21 Capital One
Rexford Industrial upgraded to Overweight from Equalweight at Capital One
06/07/21 Wells Fargo
Rexford Industrial price target raised to $58 from $51 at Wells Fargo
10/28/20 Berenberg
Rexford Industrial initiated with a Buy at Berenberg
REXR Rexford Industrial
$60.18 /

+0.02 (+0.03%)

  • 23
    Sep
  • 25
    May
  • 02
    Dec
REXR Rexford Industrial
$60.18 /

+0.02 (+0.03%)

Hot Stocks
FDA approves Pfizer, BioNTech Covid vaccine booster for certain populations » 21:02
09/22/21
09/22
21:02
09/22/21
21:02
PFE

Pfizer

$43.95 /

+0.04 (+0.09%)

, BNTX

BioNTech

$339.40 /

-2.11 (-0.62%)

The Food and Drug…

The Food and Drug Administration amended the emergency use authorization for the Pfizer (PFE) -BioNTech (BNTX) Covid-19 vaccine to allow for use of a single booster dose, to be administered at least six months after completion of the primary series in: individuals 65 years of age and older; individuals 18 through 64 years of age at high risk of severe Covid-19; and individuals 18 through 64 years of age whose frequent institutional or occupational exposure to SARS-CoV-2 puts them at high risk of serious complications of Covid-19. The authorization applies only to the Pfizer-BioNTech Covid vaccine. "The FDA considered the committee's input and conducted its own thorough review of the submitted data to reach today's decision. We will continue to analyze data submitted to the FDA pertaining to the use of booster doses of COVID-19 vaccines and we will make further decisions as appropriate based on the data," said Peter Marks, director of FDA's Center for Biologics Evaluation and Research. Reference Link

ShowHide Related Items >><<
PFE Pfizer
$43.95 /

+0.04 (+0.09%)

BNTX BioNTech
$339.40 /

-2.11 (-0.62%)

PFE Pfizer
$43.95 /

+0.04 (+0.09%)

09/20/21 Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
BNTX BioNTech
$339.40 /

-2.11 (-0.62%)

08/27/21 UBS
BioNTech price target raised to $300 from $111 at UBS
08/20/21 Canaccord
BioNTech price target raised to $450 from $240 at Canaccord
08/12/21 Wells Fargo
Wells says Moderna vaccine looks more effective than Pfizer's against Delta
PFE Pfizer
$43.95 /

+0.04 (+0.09%)

BNTX BioNTech
$339.40 /

-2.11 (-0.62%)

PFE Pfizer
$43.95 /

+0.04 (+0.09%)

PFE Pfizer
$43.95 /

+0.04 (+0.09%)

BNTX BioNTech
$339.40 /

-2.11 (-0.62%)

PFE Pfizer
$43.95 /

+0.04 (+0.09%)

Upgrade
Lufthansa upgraded to Neutral from Sell at Goldman Sachs » 20:57
09/22/21
09/22
20:57
09/22/21
20:57
DLAKY

Lufthansa

$10.29 /

+0.25 (+2.49%)

Goldman Sachs analyst…

Goldman Sachs analyst Patrick Creuset upgraded Lufthansa to Neutral from Sell with a price target of EUR 6.60, down from EUR 8.10. The analyst cites the company's outlook for positive adjusted EBIT before restructuring costs as well as its stronger trading in Cargo business expected for the second half of FY21 and FY22. Creuset adds that his reduced price target reflects Lufthansa's capital raise, partly offset by lower cash burn as a result of higher 2022/23 EBITDA estimates, and he expects the company to start generating positive free cash flows again from 2022.

ShowHide Related Items >><<
DLAKY Lufthansa
$10.29 /

+0.25 (+2.49%)

DLAKY Lufthansa
$10.29 /

+0.25 (+2.49%)

09/21/21 Credit Suisse
Lufthansa price target lowered to EUR 3.91 from EUR 4.47 at Credit Suisse
09/16/21 AlphaValue/Baader
Lufthansa downgraded to Reduce from Add at AlphaValue/Baader
08/09/21 UBS
Lufthansa price target raised to EUR 6.45 from EUR 5.90 at UBS
07/12/21 Morgan Stanley
Lufthansa price target raised to EUR 8 from EUR 5 at Morgan Stanley
DLAKY Lufthansa
$10.29 /

+0.25 (+2.49%)

Upgrade
Liberty Global upgraded to Buy from Hold at Jefferies » 20:55
09/22/21
09/22
20:55
09/22/21
20:55
LBTYA

Liberty Global

$28.48 /

+0.715 (+2.58%)

Jefferies analyst Ulrich…

Jefferies analyst Ulrich Rathe upgraded Liberty Global to Buy from Hold with a price target of $36.40, up from $28.30. Even on "cautious operational forecasts," the company's free cash flow should double over the next three years, driven by deal synergies, Rathe tells investors in a research note. Liberty has now committed to buy at least 10% of its stock annually over the next three years, the analyst adds. He believes the stock's "valuation gap" can close despite the company's complexity and strategic uncertainties.

ShowHide Related Items >><<
LBTYA Liberty Global
$28.48 /

+0.715 (+2.58%)

LBTYA Liberty Global
$28.48 /

+0.715 (+2.58%)

09/07/21 Bernstein
Liberty Global initiated with an Outperform at Bernstein
07/29/21 Deutsche Bank
Liberty Global named short-term investment idea at Deutsche Bank
06/23/21 JPMorgan
Liberty Global resumed with an Overweight at JPMorgan
05/07/21 Barclays
Liberty Global price target raised to $35 from $32 at Barclays
LBTYA Liberty Global
$28.48 /

+0.715 (+2.58%)

LBTYA Liberty Global
$28.48 /

+0.715 (+2.58%)

Syndicate
EngageSmart 14.55M share IPO priced at $26.00 » 20:52
09/22/21
09/22
20:52
09/22/21
20:52
ESMT

EngageSmart

/

+

The deal priced above the…

The deal priced above the $23.00-$25.00 range. JPMorgan, Goldman Sachs and BofA are acting as joint book running managers for the offering.

ShowHide Related Items >><<
  • 23
    Sep
Hot Stocks
Cricut holder Abdiel Capital buys 268.7K shares of common stock » 20:30
09/22/21
09/22
20:30
09/22/21
20:30
CRCT

Cricut

$31.02 /

-0.44 (-1.40%)

In a regulatory filing,…

In a regulatory filing, Cricut disclosed that its institutional holder Abdiel Capital bought 268.7K shares of common stock on September 20th in a total transaction size of $8.17M, boosting its stake by about 1%. Shares of Cricut are up 5.7% after-hours.

ShowHide Related Items >><<
CRCT Cricut
$31.02 /

-0.44 (-1.40%)

CRCT Cricut
$31.02 /

-0.44 (-1.40%)

08/17/21 Barclays
Cricut downgraded to Equal Weight from Overweight at Barclays
08/13/21
Fly Intel: Top five analyst downgrades
08/13/21 Goldman Sachs
Cricut downgraded to Neutral from Buy at Goldman Sachs
08/13/21 Morgan Stanley
Cricut downgraded to Underweight from Equal Weight at Morgan Stanley
CRCT Cricut
$31.02 /

-0.44 (-1.40%)

  • 25
    Mar
CRCT Cricut
$31.02 /

-0.44 (-1.40%)

CRCT Cricut
$31.02 /

-0.44 (-1.40%)

Earnings
Notable companies reporting before tomorrow's open » 20:25
09/22/21
09/22
20:25
09/22/21
20:25
DRI

Darden

$150.35 /

+3.72 (+2.54%)

, RAD

Rite Aid

$15.25 /

+0.18 (+1.19%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include Darden Restaurants (DRI), consensus $1.63... Rite Aid (RAD), consensus (42c).

ShowHide Related Items >><<
RAD Rite Aid
$15.25 /

+0.18 (+1.19%)

DRI Darden
$150.35 /

+3.72 (+2.54%)

DRI Darden
$150.35 /

+3.72 (+2.54%)

09/15/21 RBC Capital
RBC Capital estimating in-line Q1 earnings for Darden
08/09/21
Fly Intel: Top five analyst downgrades
08/09/21 Evercore ISI
Darden downgraded to In Line from Outperform at Evercore ISI
08/09/21 Evercore ISI
Darden downgraded to In Line from Outperform at Evercore ISI
RAD Rite Aid
$15.25 /

+0.18 (+1.19%)

06/25/21
Fly Intel: Top five analyst downgrades
06/25/21 JPMorgan
Rite Aid downgraded to Underweight from Neutral at JPMorgan
06/25/21 Deutsche Bank
Rite Aid price target lowered to $13 from $18 at Deutsche Bank
06/22/21 Deutsche Bank
Rite Aid price target lowered to $18 from $27 at Deutsche Bank
RAD Rite Aid
$15.25 /

+0.18 (+1.19%)

DRI Darden
$150.35 /

+3.72 (+2.54%)

RAD Rite Aid
$15.25 /

+0.18 (+1.19%)

DRI Darden
$150.35 /

+3.72 (+2.54%)

RAD Rite Aid
$15.25 /

+0.18 (+1.19%)

DRI Darden
$150.35 /

+3.72 (+2.54%)

RAD Rite Aid
$15.25 /

+0.18 (+1.19%)

DRI Darden
$150.35 /

+3.72 (+2.54%)

Syndicate
Grinrod Shipping 1.842M share Spot Secondary priced at $13.50 » 20:20
09/22/21
09/22
20:20
09/22/21
20:20
GRIN

Grinrod Shipping

$15.57 /

-0.92 (-5.58%)

The deal priced at low…

The deal priced at low end of $13.50-$14.00 range. Jefferies is acting as lead book running manager for the offering.

ShowHide Related Items >><<
GRIN Grinrod Shipping
$15.57 /

-0.92 (-5.58%)

  • 23
    Sep
Syndicate
Safehold 2.2M share Secondary priced at $76.00 » 20:18
09/22/21
09/22
20:18
09/22/21
20:18
SAFE

Safehold

$76.42 /

-3.56 (-4.45%)

The deal size was…

The deal size was increased to 2.2M shares from 2.0M and priced below last closing price of $76.57. Goldman Sachs, BofA, JPMorgan and Morgan Stanley are acting as joint book running managers for the offering.

ShowHide Related Items >><<
SAFE Safehold
$76.42 /

-3.56 (-4.45%)

SAFE Safehold
$76.42 /

-3.56 (-4.45%)

09/21/21
Safehold files to sell 2M shares and concurrent private placement
07/30/21 Truist
Safehold price target raised to $80 from $72 at Truist
07/27/21 B. Riley
Safehold price target raised to $110 from $100 at B. Riley
07/22/21 Truist
Truist 'not overly concerned' by Safehold earnings miss
SAFE Safehold
$76.42 /

-3.56 (-4.45%)

  • 23
    Sep
  • 11
    Nov
SAFE Safehold
$76.42 /

-3.56 (-4.45%)

Hot Stocks
Aerojet Rocketdyne conducts 'solid rocket motor test firing' at Arkansas site » 19:42
09/22/21
09/22
19:42
09/22/21
19:42
AJRD

Aerojet Rocketdyne

$41.32 /

-0.665 (-1.58%)

Aerojet Rocketdyne…

Aerojet Rocketdyne "recently conducted a solid rocket motor test firing that demonstrated the successful transition of large solid rocket motor mix, cast and test operations from Sacramento, California, to its Camden, Arkansas, site. The motor was cast at Camden's Engineering, Manufacturing and Development facility, which was officially opened last October. Aerojet Rocketdyne has been steadily building its capabilities and team at its Camden site, growing its workforce by more than 70% over the past five years. The test firing of the eSR-73 demonstration motor builds upon work performed by Aerojet Rocketdyne for the U.S. Air Force Research Laboratory on the Missile Components Advanced Technologies Demonstration Motor program. The MCAT Demo motor was successfully test-fired last year at the Utah Test and Training Range. Both tests demonstrated state-of-the-art graphite composite cases, affordable advanced nozzles and high-energy, long-life solid propellant. The eSR-73 is a step closer to production readiness and served as a pathfinder for producing and handling large solid rocket motors at Aerojet Rocketdyne's Camden site."

ShowHide Related Items >><<
AJRD Aerojet Rocketdyne
$41.32 /

-0.665 (-1.58%)

AJRD Aerojet Rocketdyne
$41.32 /

-0.665 (-1.58%)

04/27/21 Truist
Aerojet Rocketdyne price target lowered to $51 from $56 at Truist
01/07/21 Jefferies
Jefferies downgrades Aerojet Rocketdyne to Hold, sees higher bid as unlikely
01/07/21 Jefferies
Aerojet Rocketdyne downgraded to Hold from Buy at Jefferies
12/22/20 Credit Suisse
Lockheed Martin price target raised to $409 from $400 at Credit Suisse
AJRD Aerojet Rocketdyne
$41.32 /

-0.665 (-1.58%)

AJRD Aerojet Rocketdyne
$41.32 /

-0.665 (-1.58%)

AJRD Aerojet Rocketdyne
$41.32 /

-0.665 (-1.58%)

Hot Stocks
Buenaventura announces strike at Uchucchacua Mine » 19:38
09/22/21
09/22
19:38
09/22/21
19:38
BVN

Buenaventura

$7.53 /

+0.17 (+2.31%)

Compania de Minas…

Compania de Minas Buenaventura announced that the local community surrounding the Company's Uchucchacua mine initiated a strike at midnight on September 13, 2021. Mine operations have therefore since been suspended as access has been blocked. However, essential work associated with mine maintenance and functionality, including water drainage, water treatment and tailings dams inspection, continue without interruption.

ShowHide Related Items >><<
BVN Buenaventura
$7.53 /

+0.17 (+2.31%)

03/08/21 Citi
Buenaventura price target lowered to $12 from $13 at Citi
12/15/20 Goldman Sachs
Buenaventura downgraded to Neutral from Buy at Goldman Sachs
Syndicate
Brilliant Earth 8.33M share IPO priced at $12.00 » 19:25
09/22/21
09/22
19:25
09/22/21
19:25
BRLT

Brilliant Earth

/

+

The deal size was reduced…

The deal size was reduced to 8.33M shares from 16.67M and priced below target range of $14.00-$16.00 JPMorgan, Credit Suisse, Jefferies and Cowen are acting as joint book running managers for the offering.

ShowHide Related Items >><<
  • 23
    Sep
Conference/Events
Yum China to hold virtual investor day » 19:25
09/22/21
09/22
19:25
09/22/21
19:25
YUMC

Yum China

$54.43 /

+0.3 (+0.55%)

Virtual Investor Day to…

Virtual Investor Day to be held on September 22 at 8 pm. Webcast Link

ShowHide Related Items >><<
YUMC Yum China
$54.43 /

+0.3 (+0.55%)

YUMC Yum China
$54.43 /

+0.3 (+0.55%)

09/20/21 Stifel
Starbucks price target trimmed to $130 at Stifel after Yum China disclosures
09/15/21 Macquarie
Macquarie downgrades Yum China to sell on 'bumpy' sales recovery
09/15/21 Macquarie
Yum China downgraded to Underperform from Neutral at Macquarie
07/07/21 Goldman Sachs
Yum China price target raised to $77 from $74 at Goldman Sachs
YUMC Yum China
$54.43 /

+0.3 (+0.55%)

YUMC Yum China
$54.43 /

+0.3 (+0.55%)

YUMC Yum China
$54.43 /

+0.3 (+0.55%)

Hot Stocks
Ingredion raises quarterly dividend to 65c per share from 64c » 19:22
09/22/21
09/22
19:22
09/22/21
19:22
INGR

Ingredion

$87.47 /

+0.305 (+0.35%)

The dividend is payable…

The dividend is payable on October 25, 2021, to stockholders of record at the close of business on October 4, 2021.

ShowHide Related Items >><<
INGR Ingredion
$87.47 /

+0.305 (+0.35%)

INGR Ingredion
$87.47 /

+0.305 (+0.35%)

09/10/21 Lake Street
S&W Seed pact with Ingredion a 'potential needle-mover,' says Lake Street
05/05/21 Stephens
Stephens downgrades Ingredion to Equal Weight on lower beat and raise potential
05/05/21 Stephens
Ingredion downgraded to Equal Weight from Overweight at Stephens
INGR Ingredion
$87.47 /

+0.305 (+0.35%)

INGR Ingredion
$87.47 /

+0.305 (+0.35%)

Syndicate
Sovos Brands 23.3M share IPO priced at $12.00 » 19:21
09/22/21
09/22
19:21
09/22/21
19:21
SOVO

Sovos Brands

/

+

The deal priced below the…

The deal priced below the $14.00-$16.00 range. JPMorgan and Goldman Sachs are acting as joint book running managers for the offering.

ShowHide Related Items >><<
  • 23
    Sep
Syndicate
Sterling Check 14.285M share IPO priced at $23.00 » 19:10
09/22/21
09/22
19:10
09/22/21
19:10
STER

Sterling Check

/

+

The deal priced above the…

The deal priced above the $20.00-$22.00 range. Goldman Sachs, JPMorgan and Morgan Stanley are acting as joint book running managers for the offering.

ShowHide Related Items >><<
  • 23
    Sep
Hot Stocks
Amazon Web Services to open data centers in New Zealand » 18:53
09/22/21
09/22
18:53
09/22/21
18:53
AMZN

Amazon.com

$3,380.08 /

+33.19 (+0.99%)

Amazon Web Services…

Amazon Web Services announced plans to open an infrastructure region in Aotearoa New Zealand in 2024. The new AWS Asia Pacific Region will consist of three Availability Zones and join the existing 81 Availability Zones across 25 geographic AWS Regions at launch. The Region will be owned and operated by a local AWS entity in New Zealand. Globally, AWS has announced plans for 24 more Availability Zones and eight more AWS Regions in Australia, India, Indonesia, Israel, Spain, Switzerland, the United Arab Emirates, and the new AWS Region in New Zealand. "AWS supports thousands of organizations across New Zealand in their drive to innovate, succeed, and grow globally. AWS Cloud technology is providing new ways for government to further engage with citizens, for enterprises to innovate for their next phase of growth, and for entrepreneurs to build businesses and compete on a global scale," said Prasad Kalyanaraman, Vice President of Infrastructure Services, AWS. "Our investments reflect AWS's deep and long-term commitment to New Zealand. We are excited to build new world-class infrastructure locally, train New Zealanders with in-demand digital skills, and continue to help local organizations deliver applications that accelerate digital transformation and fuel economic growth." Amazon said it intends to invest NZ$7.5B in New Zealand over the next 15 years through the new AWS Asia Pacific Region, which includes capital expenditures on the construction of data centers, operational expenses such as ongoing utilities and facility costs, and purchases of goods and services from regional businesses.

ShowHide Related Items >><<
AMZN Amazon.com
$3,380.08 /

+33.19 (+0.99%)

AMZN Amazon.com
$3,380.08 /

+33.19 (+0.99%)

09/14/21 Evercore ISI
Amazon price target raised to $4,700 from $4,200 at Evercore ISI
09/13/21
Fly Intel: Top five analyst initiations
09/13/21 Goldman Sachs
Amazon.com initiated with a Buy at Goldman Sachs
09/10/21 BofA
Affirm price target raised to $119 from $82 at BofA
AMZN Amazon.com
$3,380.08 /

+33.19 (+0.99%)

AMZN Amazon.com
$3,380.08 /

+33.19 (+0.99%)

AMZN Amazon.com
$3,380.08 /

+33.19 (+0.99%)

AMZN Amazon.com
$3,380.08 /

+33.19 (+0.99%)

Hot Stocks
TScan Therapeutics director buys 5K shares of common stock » 18:52
09/22/21
09/22
18:52
09/22/21
18:52
TCRX

TScan Therapeutics

$6.19 /

-0.23 (-3.58%)

In a regulatory filing,…

In a regulatory filing, TScan Therapeutics disclosed that its Chief Scientific Officer Gavin Macbeath bought 5K shares of common stock on September 20th in a total transaction size of $31K, boosting his stake by 11%.

ShowHide Related Items >><<
TCRX TScan Therapeutics
$6.19 /

-0.23 (-3.58%)

TCRX TScan Therapeutics
$6.19 /

-0.23 (-3.58%)

08/13/21 Cowen
Cowen sees upside for TScan Therapeutics, starts with Outperform
08/13/21 Cowen
TScan Therapeutics initiated with an Outperform at Cowen
08/10/21 Jefferies
TScan Therapeutics initiated with a Buy at Jefferies
08/10/21 Morgan Stanley
TScan Therapeutics initiated with an Overweight at Morgan Stanley
TCRX TScan Therapeutics
$6.19 /

-0.23 (-3.58%)

  • 16
    Jul
TCRX TScan Therapeutics
$6.19 /

-0.23 (-3.58%)

Hot Stocks
Amplitude Healthcare Acquisition Corp stockholders approve Jasper combination » 18:42
09/22/21
09/22
18:42
09/22/21
18:42
AMHC

Amplitude Healthcare Acquisition Corp

$10.22 /

-0.28 (-2.67%)

Amplitude Healthcare…

Amplitude Healthcare Acquisition Corp announced that its stockholders voted to approve the previously announced business combination with Jasper Therapeutics and all other proposals presented at AMHC''s special shareholder's meeting held on September 22, 2021.

ShowHide Related Items >><<
AMHC Amplitude Healthcare Acquisition Corp
$10.22 /

-0.28 (-2.67%)

Syndicate
Inotiv prices upsized $125M convertible senior note offering » 18:39
09/22/21
09/22
18:39
09/22/21
18:39
NOTV

Inotiv

$34.21 /

-15.715 (-31.48%)

The initial conversion…

The initial conversion rate is 21.7162 common shares per $1,000 principal amount of notes, which represents an initial conversion price of approximately $46.05 per common share. The initial conversion price represents a premium of approximately 35% over the last reported sale price of $34.11 per common share on September 22, 2021.

ShowHide Related Items >><<
NOTV Inotiv
$34.21 /

-15.715 (-31.48%)

NOTV Inotiv
$34.21 /

-15.715 (-31.48%)

09/22/21 Craig-Hallum
Inotiv price target raised to $57 from $45 at Craig-Hallum
09/20/21 Craig-Hallum
Craig-Hallum bullish on Inotiv, initiates with a Buy
09/20/21 Craig-Hallum
Inotiv initiated with a Buy at Craig-Hallum
NOTV Inotiv
$34.21 /

-15.715 (-31.48%)

  • 21
    Apr
NOTV Inotiv
$34.21 /

-15.715 (-31.48%)

Recommendations
Gazprom price target raised to $12 from $10.50 at Goldman Sachs » 18:33
09/22/21
09/22
18:33
09/22/21
18:33
OGZPY

Gazprom

$9.29 /

+0.13 (+1.42%)

Goldman Sachs analyst…

Goldman Sachs analyst Geydar Mamedov raised the firm's price target on Gazprom to $12 from $10.50 and keeps a Buy rating on the shares. The analyst said that a supply crunch and "extreme" physical tightness in the European gas market have pushed gas prices to record highs, adding that gas inventories remain at historical lows. Mamedov added that Gazprom is a major beneficiary of the current strength in gas prices as roughly 60% of its EBITDA is generated from gas sales in Europe.

ShowHide Related Items >><<
OGZPY Gazprom
$9.29 /

+0.13 (+1.42%)

06/25/21 UBS
Gazprom upgraded to Buy on higher gas prices at UBS
06/25/21 UBS
Gazprom upgraded to Buy from Neutral at UBS
06/10/21 Erste Group
Gazprom upgraded to Hold from Sell at Erste Group
12/23/20 JPMorgan
Gazprom upgraded to Overweight from Neutral at JPMorgan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.